We present here a new approach for non-invasive high resolution whole-body vascular imaging in depth by combining water-soluble and bright SWIR-emitting gold nanoclusters revealing an anisotropic surface charge with Monte Carlo image processing of the images. We applied and validated this approach to quantify vessel complexity in transgenic mice presenting vascular disorders.
visible region, they were able to reach a high spatial and temporal resolution through a few millimeters of tissue sufficient to image brain blood circulation through the intact skull2 and in ischemic femoral arteries3. Using SWIR imaging, Bawendi et al. recently evaluated the metabolic turnover rates of lipoproteins in several organs in real-time as well as the heartbeat and breathing rates in awake and unrestrained animals4. Based on these data, they generated a detailed three-dimensional quantitative flow map of the mouse brain vasculature, which demonstrates the high potential of SWIR-imaging applications.
However, only few SWIR emitting contrast agents are available that possess high quantum yields (QYs), good biocompatibility and low accumulation in organs. Although in vivo imaging studies have been performed using SWIR-emitting quantum dots (QDs)4, the down-converted emission of lanthanide-based nanomaterials5, and new organic donoracceptor-donor (D-A-D) type organic fluorophores6, these materials still have some drawbacks.
This includes for example, their possible toxicity related to the toxicity of their constituents in the case of most QDs and low QYs < 1 % for the organic molecules. A relatively new class of NIR II emitters are ultra-small gold nanoclusters (Au NCs). Recent studies with Au NCs stabilized by zwitterionic sulfobetaine ligands (AuZw) showing a high QY (3.8%), enabled to detect blood vessels using photoluminescence (PL) and revealed efficient renal clearance7.
In this work, we developed a new type of water-soluble Au NCs with emission in the SWIR, which exhibit a high brightness, a high photostability, long blood circulation times, and a low toxicity. We demonstrate the ability of this promising new contrast agent to image the vascular network of mice with vascular disorders in the second window of the SWIR spectrum (1250-1700 nm) with a more than one-fold enhancement in spatial resolution enabled by the use of Monte Carlo image processing. The non-invasive imaging processing, segmentation and analyzes were validated in transgenic mice inactivated for the Growth factor Bmp9 that were previously described with vascular disorders8-9 based on the measurement of the fractal dimension of vessels.
The here developed Au NCs, named AuMHA/TDT, were prepared by a wet chemistry route using mercaptohexanoic acid (MHA) and tetra(ethyleneglycol) dithiol (TDT) as co-ligands with the molar ratio Au: ligand =1:4 and MHA: TDT= 1:3 (Figure 1a , see SI for the experimental details). Mass spectrometry revealed a high monodispersity of an 11 kDa species ( Figure S1) . The average size of the semi-crystalline metal core was determined by high resolution transmission electron microscopy (HR-TEM) to 2.10.6 nm (Figures 1b, S2 ) and the hydrodynamic diameter of AuMHA/TDT in water to 1.900.02 nm as derived from DOSY-NMR ( Figure S3) . Illumination studies in water, with NaCl (0.9%), and in the presence of bovine serum albumin (BSA;50 mg/mL) at different incubation times demonstrate the high photostability of these emitters ( Figure S7) . Surprisingly, in the presence of blood, the PL increases over time. A similar behavior has also been reported for ICG 13 and is tentatively ascribed to specific interactions with proteins/complement components or uptake by red blood cells.
Cytotoxicity experiments (not shown) have been conducted using MTT assays with a human embryonic cell line (HEK 293) and human (U87, Colo 829) or murine (4T1) cancer cell lines in the presence of increasing concentrations of AuMHA/TDT up to 90 M (1 mg/mL). The absence of significant cell death suggests the low toxicity of these contrast agents and allowed us to move forward to in vivo studies.
The half-life of Au NCs in mice is highly dependent on the hydrodynamic diameter of the NCs 11, 14 and their density15. For instance, small Au25SG18 NCs show an extremely fast clearance with a half-life of less than 2 min as compared to 6 min for the larger AuZw 11. By elemental analysis (ICP-MS) after AuMHA/TDT administration, we measured a half-life of t1/2= 0.430.05 h and a half-elimination of t1/2 = 19.54 ±0.05 h in nude mice (Figure 2a) . These two values are more than 5 times longer than those obtained with the previous applied Au NCs. This prolonged blood circulation time enables the detection of SWIR signals from AuMHA/TDT in the blood vessels in mice up to 30 minutes after injection.
In vivo fluorescence measurements also show the renal clearance of these ultra-small particles with signal in the bladder at 3h post injection and with an elimination from the liver observed between 5h to 24h, respectively (Figure 2b) .
One of the major advantages of the SWIR spectral window is the low autofluorescence, which enables to reduce the amount of the contrast agent necessary to achieve a high signal to noise ratio. In our case, we could detect AuMHA/TDT NCs in in vitro samples at concentrations as low as 80 nM with a signal-to-noise ratio of 5.5 (Figure S8) . This enabled us to follow the biodistribution of AuMHA/TDT in mice by fluorescence imaging after 5 h or 24 h postinjection.
Results from ex vivo fluorescence measurements in different organs (Figure 2b) , confirmed by ICP-MS measurements (Figure S9) Under these conditions, the AuMHA/TDT NCs provided a clear and outstanding visualization of the vascular network as shown in movie 1.
As expected, there is a clear improvement of the spatial resolution in the SWIR is strongly improved as compared to the NIR I (Figure S10) . Despite this very good in vivo spatial resolution, we nevertheless performed post-image processing with the Monte Carlo Constrained Restoration (MCR) method to further improve the spatial resolution in depth and to overcome the scattering from the skin and the tissues. Image processing greatly enhances the spatial resolution as seen in Figure 3a . Comparing the quality of the images before and after MCR using a quantitative measure of the contrast (Figure 3b) demonstrates an improvement in contrast by one order of magnitude, highlighting the potential of this restoration. The determination of the transverse section of blood vessels from the SWIR images of a mouse leg depicted in Figure 3c highlights the excellent resolution after MCR processing and the ability to obtain highly detailed in vivo imaging of the whole-body blood vasculature and of the blood brain vasculature (Figure S11) .
Image processing was then pushed one step further using a high-pass filter to reduce scattering deeper under the skin. Restorations of the first movie by MCR plus the high pass filter underline the striking improvement of the resolution (movie 2) allowing the visualization of the vascular network at more than 4 mm penetration depth (Figure 4a) . We could also easily track the contrast agent (SWIR-emitting AuMHA/TDT) in mice especially in the first seconds after injection (movie 3, Figure 4b) .
To demonstrate the potential of combining SWIR imaging, image restoration, and image analysis for biomedical applications, non-invasive vascular imaging was performed in mice previously described with vascular disorders due to the inactivation of the gene encoding Bmp9 [8] [9] and compared to wild-type mice (WT). Bmp9 has been identified as a high affinity ligand for the endothelial specific receptor ALK1 (activin receptor-like kinase 1), that is mutated in the rare vascular disease HHT (hereditary Haemorrhagic Telangiectasia)16 . We have recently shown that Bmp9 deletion in the 129/Ola genetic background results in dilated liver vessels that ultimately lead to liver fibrosis9.
Bmp9-KO mice and WT mice were placed in supine position and were injected intravenously with AuMHA/TDT for real-time SWIR imaging from t=0 to t=15 min. MCR was performed on raw images followed by Frangi's filtering and segmentation (see methods in SI) as illustrated in Figure 5a . Then, analyses of the segmentation, which provides blood network mapping were plotted considering the length of the vessels or the number of vessel "branches" (segments delimited by forks or crossings) as a function of the fractal dimension (Figure 5b) . Fractal dimensional is referred here as the level of complexity of vessels with a numerical value between 1 (straight line tube) to 2 (highly swaying vessel in 2-dimensional section). Analyses show a clear distinction in skin vessels between Bmp9-KO and WT mice considering both vessel lengths and branches. The significant 4% increase of the fractal dimension for Bmp9-KO compared to WT mice, which is correlated to the vessel distortion, confirms then the hypothesis of tortuous vessels due to a defect in vessel maturation9. Thus, this non-invasive method allowed us for the first time to detect a vascular disorder present in the Bmp9-KO mice with such a high level of precision.
In conclusion, we report here the design of a new bright SWIR-emitting contrast agent with prolonged circulation and efficient elimination that enables the visualization of the vascular network with enhanced-spatial resolution in depth using a series of MCR processing steps. Both image processing and segmentation analyses enabled to distinguish non-invasively vascular disorders in mice with good confidence. To the best of our knowledge, this is the first time that such results were obtained non-invasively in depth and in real time using whole-body optical imaging. This study also highlights the considerable advantages of combined research on new contrast agents and on image processing and analyses to improve the sensitivity of SWIR imaging for advanced biomedical applications.
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